Table 3. False-positive report probability analysis for significant findings derived from TRMT61B rs4563180 and hepatoblastoma risk.

Genotype	OR (95% CI)	P a	Statistical power b	Prior probability
				0.25	0.1	0.01	0.001	0.0001
GC vs. GG	0.65 (0.49-0.85)	0.002	0.411	0.014	0.040	0.314	0.822	0.979
GC/CC vs. GG	0.66 (0.51-0.85)	0.002	0.450	0.011	0.033	0.272	0.791	0.974
<17 months	0.61 (0.43-0.88)	0.008	0.326	0.072	0.188	0.719	0.963	0.996
Female	0.57 (0.38-0.86)	0.008	0.230	0.092	0.234	0.770	0.971	0.997
Stage I+II	0.66 (0.46-0.93)	0.018	0.459	0.107	0.265	0.799	0.976	0.998
Stage III+IV	0.55 (0.34-0.88)	0.012	0.210	0.148	0.343	0.852	0.983	0.998

OR, odds ratio; CI, confidence interval.

^aChi-square test was used to calculate the genotype frequency distributions.

^bStatistical power was calculated using the number of observations in each subgroup and the corresponding ORs and P values in this table.